Precision Health,
Executed.

MENA's First Dynamic Biological Performance OS · Built in the UAE

Founders

Mustafa Maghraby · Mariam Hourani

Stage

Live · 80+ customers · 8 partnerships

For

Hub71 · Apr 2026

01 / 10

The 60-Second Pitch

From the founders behind a UAE strategic exit (DUBZ → Emirates Group) and a 7-year MENA precision-nutrition brand (RawKure) — Neotrium is MENA's first precision-health operating system: a closed-loop platform that aggregates DNA, blood biomarkers and wearables, then executes a DNA-matched meal plan that updates weekly as the client's biology changes. The only platform in the region that collects 360° biological data and executes against it.

Health is integrated. Healthcare is segregated. We bridge the gap.

Live

AED 200K YTD

80+ customers · 8 partnerships · zero paid marketing.

Strategic

M42 NDA Active

Mubadala-adjacent dialogue. Inside Abu Dhabi's healthcare ecosystem.

Aligned

UAE 2031 · AI 2027

Longevity mandate × AI-native government. Two converging tailwinds.

Pitch

02 / 10

Why Abu Dhabi · Why Now

Three converging mandates. Neotrium sits at the intersection.

Abu Dhabi is making three large, simultaneous bets — on longevity, on AI-native government, and on a vertically-integrated healthcare champion. A precision-health OS built in MENA contributes to all three at once.

01 · Longevity

UAE Vision 2031 & the longevity mandate

National healthspan targets, rising chronic-disease burden, and the world's highest concentration of HNW health-spend per capita outside the US. The infrastructure exists; the personalised execution layer doesn't.

UAE Vision 2031 · National Wellbeing Strategy

02 · AI

Abu Dhabi · AI-native government by 2027

The AD government's stated goal is to be the world's first AI-native government by 2027. Hub71+ AI is structured around it. NEO-OS is a clinical AI knowledge engine — a real applied-AI use case in regulated healthcare.

Hub71+ AI announcement · Oct 2025

03 · Healthcare

The Mubadala healthcare thesis

M42, Pure Health, Cleveland Clinic AD, NYUAD — Abu Dhabi has built infrastructure and diagnostics depth. What's missing is a precision-execution layer that closes the loop between data and daily behaviour. That layer is Neotrium.

M42 (Mubadala × G42 JV) · Pure Health · Cleveland Clinic AD

Why AD

03 / 10

Meet the Team

Two founders. Five clinicians.

Mustafa Maghraby

Co-Founder & Chief Systems Architect

Founded & exited DUBZ to Emirates Group. 10+ years building UAE tech & ops companies. Architected 80% of NEO-OS — knowledge base, prioritisation engine, dashboards.

Mariam Hourani

Co-Founder & Precision Nutrition Architect

Founded RawKure (2019) — 7-year MENA precision-nutrition brand. Stanford-certified Nutritionist. Architect of Neotrium's 40+ biological-parameter recipe-tag system.

Clinical Advisory Board · 5 specialists signed

Sumaia Alkhub

Functional Medicine

Zeina Maktabi · RD

Functional Medicine

Dr Tasnim El Gendy

General Practitioner

Joanne Ghanem

Clinical Dietician · Nutrigenomics

Dr Milad Mansoori

Clinical Dietician · Nutrigenomics

Team

04 / 10

NEO-OS · The AI Engine

Specialist-verified clinical AI. The IP no competitor can replicate.

The only platform in MENA that collects 360° biological data and executes against it — DNA, biomarkers, wearables in; a meal plan that updates weekly as biology changes out.

Live Product · NEO-OS

NEO-OS app — DNA-matched meal recommendations with CGM trend and least-recommended foods

NEO Score · gene + sleep insight · compliance scorecards.

★ Knowledge Base · Brain

Proprietary "if-then" rule database

Specialists encode clinical protocols as machine-readable rules. IF MTHFR · THEN REQUIRE Methyl-Folate. 40+ biological parameters. This is the IP we license.

★ Prioritisation · Decision

Rule: Dynamic > Static

Real-time data overrides genetic baselines. IF Warrior Gene AND High Stress · THEN Adrenal Recovery. The system reasons across DNA, biomarkers, wearables continuously.

★ Protocol · Weekly Adaptation

The meal plan that changes as you change

Every week, NEO-OS regenerates the client's plan against the latest biomarkers, wearable data, and protocol edits. No competitor in MENA closes this loop.

★ Human-in-the-Loop · Learning

Every edit becomes a permanent rule

Specialist amends — "swap salmon, histamine sensitivity" → IF DAO variant · THEN remove histamine foods. Logged. Permanent. The most comprehensive genomic-nutrition rule engine in MENA.

80% of platform built · final 20% in current sprint · clinical advisory bench validates every rule. Built in MENA. Licensable across the GCC.

AI Engine

05 / 10

Live Traction · Apr 2026

We didn't build a deck. We built a business.

Revenue YTD

AED /200K

Three channels live · zero paid marketing · 4 months of operation.

Monthly Run-Rate

AED /50K

~AED 40–45K MRR · subscription-led · growing organically.

Active Customers

80+

~30 active in last 30 days · 100 people served including family extensions.

Multi-Month Retention

47%

Of customers who complete the initial program, 47% convert to recurring monthly meal plans.

✓

Licensed PartnersDHA / DOH-certified lab network · clinical practitioners onboarded & active.

↗

8 Partnerships in 60 DaysAll inbound · zero outbound prospecting. Distribution channels signed and live.

✓

Asset-Light FulfilmentContracted dark-kitchen partner cooking against our recipe-tag IP. No capex.

!

App in Final Sprint80% of platform built · final 20% to remove manual ops · production this quarter.

Traction

06 / 10

Strategic Ecosystem · Eight Partnerships in 60 Days

We're not selling to the market — the ecosystem is calling.

★ Mubadala-Adjacent · The signal that matters most

M42 — Mubadala × G42 healthcare JV

Mutual NDA active. Strategic conversation open with Abu Dhabi's anchor healthcare platform. M42 is built around precision medicine and AI-driven diagnostics — Neotrium is the precision-execution layer that closes the loop between their data infrastructure and daily patient behaviour.

For Hub71 leadership: this is dialogue inside the parent ecosystem.

Signed / Live

Valeo

Largest funded MENA longevity platform. Mutual referral signed.

VEO × Emaar

White-label across 4 Dubai properties. Finalising.

Almond Blossom Fertility

Live patient referrals · 2 active.

MENOVIVRE

Dr. Tasnim · live clinical channel.

Meal Planet

B2B aggregator · 430 orders Q1.

Clinical Bench

5 specialists signed.

In Dialogue / Inbound

Everwell · Arada Group

Regenerative-medicine clinic · inbound this week.

Omics Longevity

Referral partnership agreed.

All inbound — none of these were outbound prospecting. Distribution channels, not pipeline.

Ecosystem

07 / 10

Hub71 Fit · Dual-Track

Two of Hub71's three flagship ecosystems. One company.

Most applicants are Life Sciences or AI. Neotrium is both — and the intersection is where Abu Dhabi's strategic agenda actually lives.

★ The SaaS Product · Clinic Dashboard

NEO-OS clinic dashboard — client roster, critical actions, biological age clocks

What we license to GCC clinics from Year 3 · 85% gross margin

Hub71+ Life Sciences

Precision medicine, operationalised.

→ DOH / DHA-licensed clinical pathway live
→ 5-clinician advisory bench · every protocol verified
→ M42 dialogue active — Mubadala-adjacent

Hub71+ AI

Applied AI in regulated healthcare.

→ 40+ biological-parameter rule engine · proprietary IP
→ Specialist-in-the-loop · every edit logs a permanent rule
→ Y3: most valuable genomic-nutrition dataset in GCC

Keyword matches: precision medicine (Life Sciences) · applied AI in regulated industries (AI). Two ecosystems. One flagship case.

Hub71 Fit

08 / 10

Updated 5-Year Model · vVC · 50% Conversion

From concierge to platform — USD 0.7M → 20M.

Revenue · USD M

Updated FM · 50% one-time → meal-plan conversion

EBITDA & Cumulative Cash · USD M

Operating profitability hits in FY3 · cash positive Q4

EBITDA Cumulative Cash

USD M	FY1	FY2	FY3	FY4	FY5
Revenue	0.69	1.76	4.63	8.98	16.05
Gross Margin	27%	24%	74%	80%	82%
EBITDA	(0.26)	(0.53)	0.94	2.98	6.32
Cumulative Cash	(0.53)	(1.12)	(0.39)	2.05	7.32

Base case: $16M FY5. $20M ambition with accelerated KSA entry & clinic ramp. FY2 EBITDA reflects deliberate capex into NEO-OS & kitchen scaling. FY3 inflection · 82% SaaS gross margin by FY5

Trajectory

09 / 10

The Ask

Three things from Hub71. One commitment from us.

We're not asking Hub71 for a cheque. We're asking for the right room, the right introductions, and a path into the cohort. In return, we relocate to Abu Dhabi and become a flagship Life Sciences × AI case study.

What we're asking for

01

30 minutes with the right Hub71 sponsor

A working session with the Life Sciences (and ideally AI) leads to test the dual-track thesis and map a path into the cohort.

02

Three strategic introductions

(i) M42 — introduction to the right counterpart inside M42 to convert the active NDA into pilot scope. (ii) Pure Health — pilot pathway for clinic licensing. (iii) DOH / ADHA — regulatory framework conversation for clinical SaaS in Abu Dhabi.

03

A path into Hub71

Hub71+ Life Sciences and/or Hub71+ AI cohort. We commit to Abu Dhabi residency and to building from ADGM.

What we contribute

A flagship dual-track case

Live, revenue-generating precision-health platform — built in MENA
Two-founder team: a UAE strategic exit (Mustafa · DUBZ → Emirates) and a 7-year MENA food brand (Mariam · RawKure)
Active dialogue with M42 — Mubadala-adjacent
5-clinician advisory bench · DHA / DOH-licensed pathway
Regional clinical-SaaS thesis with 85% target gross margin

Concrete commitments

Relocate operations to Abu Dhabi · ADGM domicile
Hire and build the AI / clinical team locally
Make AD the regional licensing HQ for GCC clinics

Mustafa Maghraby · mustafa@neotrium.com · neotrium.com Built in MENA. Ready to scale from Abu Dhabi.

The Ask

10 / 10

Precision Health,
Executed.